XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Common Shares
Class A Common Shares
Common Shares
Class B Common Shares
Preferred Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Distributions in Excess of Net Income
Total Shareholders' Equity
Noncontrolling Interest
Noncontrolling Interest
Consolidated joint venture
Noncontrolling Interest
Common Shares
Total Equity
Balance at Dec. 31, 2019     $ 387 $ 0 $ 147 $ 1,144,808 $ 1,010 $ (338,695) $ 807,657   $ 3,196 $ 64,144 $ 871,801
Balance (in shares) at Dec. 31, 2019   38,652,650     14,703,214             4,279,946  
Increase (Decrease) in Stockholders' Equity                          
Issuance Costs           (30)     (30)       (30)
Dividends and Distributions declared:                          
Preferred Stock               (1,007) (1,007)       (1,007)
Dividend Reinvestment Plan $ 14         14     14       14
Dividend Reinvestment Plan (in shares)   1,094                      
Share Based Compensation:                          
Grants     2     0     2     $ 0 2
Grants (in shares)   189,738                   1,112,862  
Amortization           2,069     2,069     $ 5,635 7,704
Change in Fair Value of Derivative Instruments (26,164)           (23,757)   (23,757)     (2,407) (26,164)
Adjustment to Record Noncontrolling Interest at Redemption Value           3,196     3,196   (3,196)   3,196
Net (loss) income (145,925)             (130,832) (130,832)     (15,093) (145,925)
Balance at Sep. 30, 2020     389 0 $ 147 1,150,057 (22,747) (470,534) 657,312   0 $ 52,279 709,591
Balance (in shares) at Sep. 30, 2020   38,843,482     14,703,214             5,392,808  
Balance at Jun. 30, 2020     388 0 $ 147 1,149,291 (27,097) (427,393) 695,336   0 $ 55,715 751,051
Balance (in shares) at Jun. 30, 2020   38,789,371     14,703,214             5,381,870  
Share Based Compensation:                          
Grants     1           1       1
Grants (in shares)   54,111                   10,938  
Amortization           766     766     $ 1,168 1,934
Change in Fair Value of Derivative Instruments 4,776           4,350   4,350     428 4,778
Net (loss) income (48,173)             (43,141) (43,141)     (5,032) (48,173)
Balance at Sep. 30, 2020     389 0 $ 147 1,150,057 (22,747) (470,534) 657,312   0 $ 52,279 709,591
Balance (in shares) at Sep. 30, 2020   38,843,482     14,703,214             5,392,808  
Balance at Dec. 31, 2020 672,249   389 0 $ 147 1,150,985 (19,275) (509,243) 623,003   0 $ 49,246 672,249
Balance (in shares) at Dec. 31, 2020   38,843,482     14,703,214             5,392,808  
Increase (Decrease) in Stockholders' Equity                          
Unit Conversion     2     2,971     2,973     $ (2,973)  
Unit Conversion (in shares)   235,750                   (235,750)  
Dividends and Distributions declared:                          
Preferred Stock               (42,306) (42,306)       (42,306)
Dividend Reinvestment Plan 0                        
Share Based Compensation:                          
Grants     2     355     357     $ 1,679 2,036
Grants (in shares)   239,998                   794,683  
Amortization           2,207     2,207     $ 3,791 5,998
Change in Fair Value of Derivative Instruments 11,571           10,422   10,422     1,149 11,571
Equity Contribution to Consolidated Joint Venture                     158    
Adjustment to Record Noncontrolling Interest at Redemption Value           (1,968)     (1,968)   1,968   (1,968)
Net (loss) income (30,365)             (25,407) (25,407)   (158) (4,800) (30,207)
Balance at Sep. 30, 2021 617,373   393 0 $ 147 1,154,550 (8,853) (576,956) 569,281   1,968 $ 48,092 617,373
Balance (in shares) at Sep. 30, 2021   39,319,230     14,703,214             5,951,741  
Balance at Jun. 30, 2021     392 0 $ 147 1,153,657 (11,024) (557,157) 586,015   1,968 $ 48,672 634,687
Balance (in shares) at Jun. 30, 2021   39,217,475     14,703,214             5,962,491  
Increase (Decrease) in Stockholders' Equity                          
Unit Conversion           101     101 $ (101)      
Unit Conversion (in shares)   10,750               (10,750)      
Dividends and Distributions declared:                          
Preferred Stock               (6,044) (6,044)       (6,044)
Share Based Compensation:                          
Grants     1           1       1
Grants (in shares)   91,005                      
Amortization           792     792     $ 1,461 2,253
Change in Fair Value of Derivative Instruments 2,408           2,171   2,171     237 2,408
Net (loss) income (15,932)             (13,755) (13,755)     (2,177) (15,932)
Balance at Sep. 30, 2021 $ 617,373   $ 393 $ 0 $ 147 $ 1,154,550 $ (8,853) $ (576,956) $ 569,281   $ 1,968 $ 48,092 $ 617,373
Balance (in shares) at Sep. 30, 2021   39,319,230     14,703,214             5,951,741